130 related articles for article (PubMed ID: 26010212)
1. Plasma antioxidant status and motor features in de novo Chinese Parkinson's disease patients.
Yuan Y; Tong Q; Zhang L; Jiang S; Zhou H; Zhang R; Zhang S; Xu Q; Li D; Zhou X; Ding J; Zhang K
Int J Neurosci; 2016; 126(7):641-6. PubMed ID: 26010212
[TBL] [Abstract][Full Text] [Related]
2. Serum glutathione peroxidase, xanthine oxidase, and superoxide dismutase activities and malondialdehyde levels in patients with Parkinson's disease.
Gökçe Çokal B; Yurtdaş M; Keskin Güler S; Güneş HN; Ataç Uçar C; Aytaç B; Durak ZE; Yoldaş TK; Durak İ; Çubukçu HC
Neurol Sci; 2017 Mar; 38(3):425-431. PubMed ID: 27900485
[TBL] [Abstract][Full Text] [Related]
3. [Study on changes of plasma levels of oxidative stress biomarkers and its relation with cognition function in patients with parkinson's disease].
Zhou H; Yuan Y; Qi Z; Tong Q; Zhang K
Zhonghua Yi Xue Za Zhi; 2015 Nov; 95(41):3357-60. PubMed ID: 26812976
[TBL] [Abstract][Full Text] [Related]
4. Relationship between the plasma levels of neurodegenerative proteins and motor subtypes of Parkinson's disease.
Ding J; Zhang J; Wang X; Zhang L; Jiang S; Yuan Y; Li J; Zhu L; Zhang K
J Neural Transm (Vienna); 2017 Mar; 124(3):353-360. PubMed ID: 27878377
[TBL] [Abstract][Full Text] [Related]
5. Erythrocyte antioxidant enzymes in Parkinson's disease.
Abraham S; Soundararajan CC; Vivekanandhan S; Behari M
Indian J Med Res; 2005 Feb; 121(2):111-5. PubMed ID: 15756044
[TBL] [Abstract][Full Text] [Related]
6. How stable are Parkinson's disease subtypes in de novo patients: Analysis of the PPMI cohort?
Simuni T; Caspell-Garcia C; Coffey C; Lasch S; Tanner C; Marek K;
Parkinsonism Relat Disord; 2016 Jul; 28():62-7. PubMed ID: 27132498
[TBL] [Abstract][Full Text] [Related]
7. Peripheral blood markers of oxidative stress in Parkinson's disease.
Younes-Mhenni S; Frih-Ayed M; Kerkeni A; Bost M; Chazot G
Eur Neurol; 2007; 58(2):78-83. PubMed ID: 17565220
[TBL] [Abstract][Full Text] [Related]
8. Distal motor deficit contributions to postural instability and gait disorder in Parkinson's disease.
Vervoort G; Bengevoord A; Nackaerts E; Heremans E; Vandenberghe W; Nieuwboer A
Behav Brain Res; 2015; 287():1-7. PubMed ID: 25804361
[TBL] [Abstract][Full Text] [Related]
9. Cerebrospinal fluid amyloid-β and phenotypic heterogeneity in de novo Parkinson's disease.
Alves G; Pedersen KF; Bloem BR; Blennow K; Zetterberg H; Borm GF; Dalaker TO; Beyer MK; Aarsland D; Andreasson U; Lange J; Tysnes OB; Zivadinov R; Larsen JP
J Neurol Neurosurg Psychiatry; 2013 May; 84(5):537-43. PubMed ID: 23117496
[TBL] [Abstract][Full Text] [Related]
10. Inhibitory motor dysfunction in parkinson's disease subtypes.
Gong T; Xiang Y; Saleh MG; Gao F; Chen W; Edden RAE; Wang G
J Magn Reson Imaging; 2018 Jun; 47(6):1610-1615. PubMed ID: 28960581
[TBL] [Abstract][Full Text] [Related]
11. Free radical toxicity and antioxidants in Parkinson's disease.
Sudha K; Rao AV; Rao S; Rao A
Neurol India; 2003 Mar; 51(1):60-2. PubMed ID: 12865518
[TBL] [Abstract][Full Text] [Related]
12. Investigation of oxidative stress in patients with alopecia areata and its relationship with disease severity, duration, recurrence and pattern.
Yenin JZ; Serarslan G; Yönden Z; Ulutaş KT
Clin Exp Dermatol; 2015 Aug; 40(6):617-21. PubMed ID: 25524272
[TBL] [Abstract][Full Text] [Related]
13. Highly specific changes in antioxidant levels and lipid peroxidation in Parkinson's disease and its progression: Disease and staging biomarkers and new drug targets.
de Farias CC; Maes M; Bonifácio KL; Bortolasci CC; de Souza Nogueira A; Brinholi FF; Matsumoto AK; do Nascimento MA; de Melo LB; Nixdorf SL; Lavado EL; Moreira EG; Barbosa DS
Neurosci Lett; 2016 Mar; 617():66-71. PubMed ID: 26861200
[TBL] [Abstract][Full Text] [Related]
14. Serum uric acid level and its association with motor subtypes and non-motor symptoms in early Parkinson's disease: PALS study.
Huang X; Ng SY; Chia NS; Acharyya S; Setiawan F; Lu ZH; Ng E; Tay KY; Au WL; Tan EK; Tan LC
Parkinsonism Relat Disord; 2018 Oct; 55():50-54. PubMed ID: 29779681
[TBL] [Abstract][Full Text] [Related]
15. Plasma lipid peroxidation and antioxidant status of Parkinson's disease patients in the Indian population.
Sharma A; Kaur P; Kumar B; Prabhakar S; Gill KD
Parkinsonism Relat Disord; 2008; 14(1):52-7. PubMed ID: 18032086
[TBL] [Abstract][Full Text] [Related]
16. White matter changes and the development of motor phenotypes in de novo Parkinson's Disease.
Moccia M; Tedeschi E; Ugga L; Erro R; Picillo M; Caranci F; Barone P; Brunetti A
J Neurol Sci; 2016 Aug; 367():215-9. PubMed ID: 27423590
[TBL] [Abstract][Full Text] [Related]
17. Oxidative stress and antioxidant enzyme activity in South Indian male smokers with chronic obstructive pulmonary disease.
Arja C; Surapaneni KM; Raya P; Adimoolam C; Balisetty B; Kanala KR
Respirology; 2013 Oct; 18(7):1069-75. PubMed ID: 23683270
[TBL] [Abstract][Full Text] [Related]
18. Oxidative stress: correlation with Behçet's disease duration, activity and severity.
Harzallah O; Kerkeni A; Baati T; Mahjoub S
Eur J Intern Med; 2008 Nov; 19(7):541-7. PubMed ID: 19013385
[TBL] [Abstract][Full Text] [Related]
19. Correlates of excessive daytime sleepiness in de novo Parkinson's disease: A case control study.
Simuni T; Caspell-Garcia C; Coffey C; Chahine LM; Lasch S; Oertel WH; Mayer G; Högl B; Postuma R; Videnovic A; Amara AW; Marek K;
Mov Disord; 2015 Sep; 30(10):1371-81. PubMed ID: 26095202
[TBL] [Abstract][Full Text] [Related]
20. Association of status redox with demographic, clinical and imaging parameters in patients with Huntington's disease.
Peña-Sánchez M; Riverón-Forment G; Zaldívar-Vaillant T; Soto-Lavastida A; Borrero-Sánchez J; Lara-Fernández G; Esteban-Hernández EM; Hernández-Díaz Z; González-Quevedo A; Fernández-Almirall I; Pérez-López C; Castillo-Casañas Y; Martínez-Bonne O; Cabrera-Rivero A; Valdés-Ramos L; Guerra-Badía R; Fernández-Carriera R; Menéndez-Sainz MC; González-García S
Clin Biochem; 2015 Dec; 48(18):1258-63. PubMed ID: 26210848
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
